We have recently developed a non-adhesive liquid embolic agent, hydroxyethylmethacrylate methylmethacrylate copolymer (HEMA-MMA), and used it for arteriovenous malformations (AVMs) in the central nervous system. To evaluate the toxicity and usefulness of this agent, we made a clinicopathological study of AVMs that were embolized with it and then excised surgically. This study includes ten cases: nine with pial AVM and one with scalp AVM. In a pathological study, special attention was paid to vascular and perivascular inflammation, angionecrosis, recanalization of the embolized vessels, and foreign body reactions. Inflammation was absent or very mild regardless of the interval between embolization and excision. There was no angionecrosis. Recanalization could be expected to occur in the partially occluded vessel. Foreign body reactions such as infiltration of monocytes or giant cells, and proliferation of fibroblasts or capillaries were also not seen in any case. It was concluded that HEMA-MMA is an excellent embolic material that is easy to handle, less vasotoxic than other agents, and highly histocompatible.
Introduction
Artificial embolization via a superselectively inserted micro catheter in feeding arteries is a modern advance for treating arteriovenous malformations (AVMs) in the central nervous system. It has now been established as a certain therapeutic modality, selected as an adjuvant therapy preceding surgical excision or radiosurgery, or as a sole treatment in case 1,2,3.
Many embolizing materials have been used in the world. We have recently developed a solution of hydroxyethylmethacrylate methylmethacrylate copolymer in low concentration ethanol and iopamidol (HEMA-MMA) as an embolizing liquid and clinically used it for AVMs 2,4,5 . To evaluate the toxicity and usefulness of this liquid, the topical tissue reaction in the embolized AVMs was evaluated in this study.
Material and Methods
Ten cases with AVMs, that were embolized with HEMA-MMA and then excised surgically, were reviewed. A summary of the cases is presented in table 1. Standard techniques were Figure 1 A case of the left temporal pial AVM (Case 6). The nidus was seated in the left temporal lobe (A) and fed by two main branches from middle cerebral artery (MCA) . Note a small aneurysm was present at the bifurcation of the branches (arrow) (B,C). The microcatheters were inserted deeply into feeders just proximally to the nidus and the embolization was done with HEMA-MMA and liquid coils one by one (D,E). The aneurysm was occluded with GDCs two weeks before the procedure. Finally, no nidal stain was seen in the arterial phase of the left carotid angiography (F,G). used to prepare the sections of the excised specimens for light microscopy. Sections were stained with hematoxylin and eosin in all cases. In two cases, elastica Van Gieson staining was also prepared for a stricter evaluation of vascular structure. In a pathological study, special attention was paid to vascular and perivascular inflammation, angionecrosis, recanalization of the embolized vessels, and foreign body reactions in the area.
Case Illustration
A 51-year-old male (Case 6) was admitted to our hospital with a history of epilepsy. A left internal carotid angiogram revealed a medium sized high flow AVM in his temporal lobe (figure lA). Two branches of the left middle cerebral artery were mainly feeding the AVM and an aneurysm was found associated with the bifurcation (figure 1B,C). At first, the aneurysm was coiled endovascularly and then the AVM was embolized using HEMA-MMA two weeks later. A microcatheter was deeply inserted into each feeding artery. However, the flow was so rapid that an injected material might have passed through the lesion and migrated into the pulmonary artery. Therefore, several liquid coils were placed in the feeding artery to reduce the blood flow (figure 1D,E), and then the liquid was introduced. Small amounts were introduced at several minute intervals until the nidus was less distinct. A total of 3 ml was injected. After the procedure, only a part of the nidus could be faintly recognized on an angiogram (figure 1F,G). Seven days later, the AVM was removed en bloc by surgery. It was technically easy and bleeding was minimal. On a histological study, angionecrosis, recanalization and foreign body reactions were absent although subendothelial infiltration of lymphocytes was minimally present (figure 2F). The patient was discharged with no neurological deficits.
Results

Clinical characteristics of HEMA-MMA
The viscosity of HEMA-MMA was sufficiently low for it to pass through a microcatheter of small caliber. The concentration of the solution could be chosen from 4 different categories according to the grade of blood flow or to the amount of shunt of the lesion. It was non-adhesive and repeated injection was possible without a repositioning of the microcatheter. It was not vasoirritable and never induced vasospasm during the embolization procedure.
Histological findings
HEMA-MMA itself did resolve and disappear from the histological specimen during the process of preparation. It was recognized as a loose network of fibrous tissue in the occluded vessels.
Vasculitis, angionecrosis
As shown in figure 2A-J, inflammation was absent or very mild in the vessel wall around HEMA-MMA regardless of the interval between embolization and excision. The intima and media were not denuded and the internal elastic lamina was intact (figure 3). There was no evidence of angionecrosis.
Recanalization
Eccentric location of the emboli and replacement of the residual lumen with the thrombus were occasional findings of this series ( figure  2D ). This is probably due to a volume reduction of the material during precipitation in the vessels.
Foreign body reaction
In this series, foreign body reactions such as infiltration of monocytes or giant cells, and proliferation of fibroblasts or capillaries were also not seen in any case, even in the chronic stage.
Discussion
Liquid materials for embolization of AVMs available today can be grossly classified into cyanoacrylate derivatives and polymer solutions 2,3,5-9.
The former, preferentially used in Europe and North America, have an ability to permeate into very small vessels by virtue of their low viscosity and to form a cast occluding the nidus. However, their adhesive character of glueing the catheter to vessel wall sometimes causes serious complications so that highly skilled techniques of operator would be required. In addition, they produce a hard mass within the nidus, which is sometimes troublesome when excised in the following surgery 2-5,8-10. Histotoxicity of cyanoacrylate derivatives causing severe vascular damage has been experimentally and clinically reported 6,11 .12.
On the other hand, polymer solutions are generally more viscous and less permeable to small caliber vessels than cyanoacrylates. Instead, they are non-adhesive and form a soft Photomicrographs of hematoxylin and eosin staining of the cases. A) focal subendothelial infiltration of inflammatory cells was seen but internal elastic lamina (IEL) was kept intact (Case 1, one day after the embolization, original magnification X 100). B) (case 2, 3 days after embolization, X50), C) (case 3,3 days, x50), showed no inflammatory changes. D) (case 4, 4 days, X25 ), showed no inflammatory reaction but maldistribution of the embolus probably due to compaction of the material during precipitation. E) (case 5, 5 days, X 10), F) (case 6, 7 days, X 100), G) (case 7, 9 days, X25), H) (case 8, 10 days, x50) , I) (case 9, 14 days, X 25), showed sparse inflammatory or vasodestructive changes. J) (case 10,4 months, X 40) showed focal endothelial deposit of hemosiderine and related infiltration of lymphocytes but vascular structures were left intact even in the locus of hemosiderosis.
mass in the nidus, rarely interfering in subsequent surgery 4,9,14, These characteristics facilitate their clinical use. Hydroxyethylmethacrylate (HEMA) has been used as a material of contact lenses, and methylmethacrylate (MMA) as bone cement for a long time. A copolymer of these materials or HEMA-MMA probably has a good affinity to the living body 2,4.
Vasculitis, angionecrosis
In this study, it was found that HEMA-MMA did not induce any serious inflammatory reactions in the surrounding structures. Many polymeric biomaterials, that have been used to embolize cerebral AVMs, were thought not to be histotoxic so much as to induce acute inflam-mation of the surrounding tissues. However, it has been reported that these materials do induce some grade of inflammation around the vessels 3,8,9,12,14,15. These materials have quite different vehicles: for example, anhydrous dimethylsulphoxide (DMSO) for EVAL, 50% ethanol for Eudragid E , and 20% ethanol for HEMA-MMA 2,8,13 . It is probable that grade of inflammation in the acute phase mostly depends upon the nature of the organic solvent used. In fact, it has been grown experimentally by one of the present authors that a high concentration (70%) of ethanol and DSMO induce angiotoxicity, but a low concentration (10%) of ethanol does not 16 . In addition, Chaloupka studied EVAL using a swine endovascular embolization model accentuated an angiotoxicity by DMSO. Then, He concluded that embolotherapy with EVAL might have a significant risk for complications 15 . He later accepted a clinical use of the solvent, but some authors are still warning against its use 17-1 9. In the presence of vasculitis, vessels may be susceptible to rupture and bleeding that may occur spontaneously or in association with surgical maneuverso In this sense, HEMA-MMA may be safer and more suitable for obliterating AVMs.
Recanalization
Precipitated polymers reduce their volume as solvents and contrast enhancing media diffuse in the blood. As a result, a single infusion of polymer solutions has a risk of incomplete occlusion even when complete occlusion can be obtained radiographic ally during the procedure 9,20 . In this study, it was occasionally seen that the emboli were located eccentrically in the occluded vessels and the crescent-shaped residual lumen was replaced with the thrombus. At least in part, this probably represents a volume compaction of embolic materials. Subsequently, the thrombus may be organized and neovascularized, providing a clue for recanalization. Repeated injection at several-minute intervals, which is safe and easy with non-adhesive materials, may prevent such an incomplete occlusion. Another mechanism of incomplete occlusion may be vascular damage caused by embolic materials. Chaloupka observed a severe vasoconstriction of the carotid artery immediately after an injection of anhydrous DMSO or EVAL mixture into the vessel in his porcine ex- 15 . Such a vasotoxic agent may also produce intimal edema and narrowing of the vascular lumen. Under theses conditions, a good amount of embolic materials can hardly be delivered to the lesion. On the other hand, HEMA-MMA is less vasoirritable because it contains small amount of low concentration ethanol. In fact, in our own experiment using a miniature swine, vasospasm was never seen when 20% ethanol was injected into its rete mirabile at various velocities. There was no remarkable vasculitis on the histological specimen. Therefore, the risk of incomplete occlusion may be much less with HEMA-MMA than with other compounds.
Foreign body reactions
Foreign body reactions were rare regardless of the interval between embolization and excision. This is in contrast to EVAL cases, in which foreign body reactions become prominent in the subacute-chronic phase following angitis in the acute phase 3,9,15 . Some polymeric implants are also known to induce immunological reac-tions. When these reactions are prolonged, proliferative or granulomatous changes may become apparent 8,12,21 . Granulation is always accompanied by proliferation of capillaries, which in turn would facilitate a recanalization of once occluded vessels.
On the other hand, growth of the granulation tissues may produce mass effects in the surrounding neural tissues 22 . Even on these points, HEMA-MMA is more histocompartible and safer than other compounds, even if used as a permanent embolic material.
Conclusion
In this study, it was demonstrated that HEMA-MMA, a new liquid embolic agent, does not induce severe inflammation, angionecrosis or foreign body reaction. Recanalization was present in a partially occluded vessel. To avoid a probable incomplete occlusion, repeated injections were possible without withdrawing a catheter.
References
It was concluded that HEMA-MMA is excellent as embolic material; that is, it is easy to handle, less vasotoxic than other materials, and highly histocompatible. Further investigations, such as a direct visualization of the embolic material in frozen sections and, radiological and histological observation of vas ore action permanency of the occlusion in animal experiments, would be required to reinforce our conclusion. We are now preparing such experiments.
